Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03314935
Title A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Incyte Corporation

Advanced Solid Tumor


INCB001158 + Paclitaxel

Cisplatin + Gemcitabine + INCB001158

Fluorouracil + INCB001158 + Leucovorin + Oxaliplatin

Age Groups: adult | senior
Covered Countries USA | BEL

Facility Status City State Zip Country Details
University of Alabama Birmingham Alabama 35294-3300 United States Details
USA Mitchell Cancer Center Mobile Alabama 36604 United States Details
UC Davis - Comprehensive Cancer Centre Sacramento California 95817 United States Details
Northwest Georgia Oncology Centers Marietta Georgia 30060 United States Details
The University of Texas MD Anderson Cancer Center Houston Texas 77030 United States Details
START San Antonio San Antonio Texas 78229 United States Details
Grand Hopital de Charleroi - Department of Medical Oncology Brussels 6000 Belgium Details
Institut Jules Bordet - Clinical Trials Conduct Unit Brussels B-1000 Belgium Details
UCL Cancer Institute London WC1E 6BT United Kingdom Details
The Christie NHS Foundation Trust Manchester M20 4BX United Kingdom Details
*Shaded cells indicate that there was no data available from for the field